ArticleDiabetology & metabolic syndrome2023

Empagliflozin ameliorates diabetic cardiomyopathy via regulated branched-chain amino acid metabolism and mTOR/p-ULK1 signaling pathway-mediated autophagy.

Lin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.